Viewing Study NCT00046033

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:07 AM
Ignite Modification Date: 2025-12-31 @ 8:15 PM
Study NCT ID: NCT00046033
Status: COMPLETED
Last Update Posted: 2011-03-01
First Post: 2002-09-18
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Dose-Relationship, Drug View
None HIV Protease Inhibitors View
None Salvage Therapy View
None Viral Load View
None RNA, Viral View
None Drug Therapy, Combination View